The Good And Bad News When It Comes To EU Notified Bodies’ Designation Capacity
Executive Summary
The entire medtech sector is all too aware of the lack of capacity among notified bodies to support the EU medical device and IVD regulations. But what really matters is how much notified body capacity there is in a given product area as this will have the most influence on conformity assessment timelines for individual products.
You may also be interested in...
80% Of MDR Device-Related Codes Are Offered By Over 20 Notified Bodies
An update is now available from the European Commission on notified body testing capacity according to product type codes.
Extensive EU Medtech Regulatory Survey Reveals Scale Of MDR Hurdles And Where Problems Lie
MedTech Europe says solutions are still urgently needed to ensure the MDR is on course and warns that 50% of companies are deprioritizing the EU as launch market, potentially denying EU citizens vital health care.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.